All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WJ1796 | Anti-NUDT9 (7F12) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 7F12 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1797 | Anti-NUDT9 (5B5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 5B5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1798 | Anti-NUDT9 (7A12) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 7A12 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1799 | Anti-NUDT9 (CBWJN-1606) h(41BB-CD3ζ) CAR, pCDCAR1 | CBWJN-1606 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4088 | Anti-NUDT9 (7F12) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7F12 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4089 | Anti-NUDT9 (5B5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 5B5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4090 | Anti-NUDT9 (7A12) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7A12 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4091 | Anti-NUDT9 (CBWJN-1606) h(CD28-CD3ζ) CAR, pCDCAR1 | CBWJN-1606 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION